PLERIXAFOR INJECTION
Google image searchProduct monograph
Active ingredient
plerixafor, 20 MG/ML
DIN: 02529815
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 31-AUG-2023
ATC:
- L03 — IMMUNOSTIMULANTS (ATC, ATC/DDD, )
- L03A — IMMUNOSTIMULANTS (ATC, ATC/DDD)
- L03AX — Other immunostimulants (ATC, ATC/DDD)
- L03AX16 — PLERIXAFOR (ATC/DDD)
Reference brand drug: Mozobil
